Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - INVIVO THERAPEUTICS HOLDINGS CORP. | a2227601zex-31_1.htm |
| EX-32.2 - EX-32.2 - INVIVO THERAPEUTICS HOLDINGS CORP. | a2227601zex-32_2.htm |
| EX-31.2 - EX-31.2 - INVIVO THERAPEUTICS HOLDINGS CORP. | a2227601zex-31_2.htm |
| EX-23.1 - EX-23.1 - INVIVO THERAPEUTICS HOLDINGS CORP. | a2227601zex-23_1.htm |
| EX-32.1 - EX-32.1 - INVIVO THERAPEUTICS HOLDINGS CORP. | a2227601zex-32_1.htm |
| 10-K - 10-K - INVIVO THERAPEUTICS HOLDINGS CORP. | a2227601z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements (File Nos. 333-205471, 333-205469, 333-183491, 333-173208, 333-176110 and 333-176111) on Form S-8 and Registration Statements (File Nos. 333-201535, 333-188573, 333-178584 and 333-171998) on Form S-3 of our report dated March 11, 2015, relating to our audit of the consolidated financial statements, which appears in the Annual Report on Form 10-K of InVivo Therapeutics Holdings Corp. for the year ended December 31, 2015.
/s/ Wolf & Company, P.C.
Wolf &
Company, P.C.
Boston, Massachusetts
March 4, 2016
1